STUDresearch · Peptide

HGH Fragment 176-191

Also known as

Frag 176-191 · HGH Frag · fragment 176 · HGH Fragment 176-191 · Fragment 176-191 · hGH Frag · hGH Fragment 176-191 · GH Frag 176-191 · hGH 176-191 · Growth hormone fragment 176-191 · C-terminal hGH fragment (community label) · hGH frag 176–191 · HGH Frag 176-191 · frag-176-191

Community talk. May be wrong. Not medical advice. Not a protocol. Not for human or animal use.

Open in the directory ↗
Peptide Lots of talk Systemic SubQ Metabolic / fat-loss peptides

Systemic fat-loss fragment peptide lore.

What people say HGH fragment 176–191 is a gray-market name for a C-terminal growth-hormone fragment. It should not be treated as identical to AOD-9604 or the 177–191 rat-research fragment, and exact product identity is often disputed. Doses people talk about
Diet/cardio-associated report100 mcg fasted morning plus 100 mcg before bed

The user described four-week blocks, sometimes separated by two weeks, and said diet/fasting/cardio were necessary for the perceived result.

Planned stacked protocol250 mcg in the morning, five days weekly for a planned ten weeks

Plan rather than outcome; combined with CJC/ipamorelin, so it cannot support fragment-specific efficacy.

Long, highly confounded report500 mcg daily, later described as 250 mcg morning plus 250 mcg before bed

The author claimed 18 months of benefit but also disclosed tirzepatide, retatrutide, GH secretagogues and many other peptides.

These rows preserve observed forum contexts only; they are not instructions, a progression or evidence that labeled products contained exact HGH fragment 176–191.

Half-life & effect duration

Half-life in the body
  • Exact 176–191 fragmentNo settled estimate
Felt duration people report
  • AccountsOften no noticeable effect
  • Positive body-change reportsAcross multi-week or longer runs with diet, cardio or other compounds
Timing context & sources
How it may feel Several users reported no noticeable fat-loss benefit, one described diet/cardio-dependent results, and an 18-month positive account disclosed multiple potent weight-loss and GH-axis compounds. No clean early sensation or reliable personal-effect duration emerges.

Tap a line to jump into the full notes. Research only — may be wrong.

Timing context & sources

Half-life in the body

No human parent-compound half-life was established for exact HGH fragment 176–191 in the checked sources.

Community schedules are not PK measurements. The primary experiment located studied hGH 177–191 in rat adipose tissue, while community sourcing discussion distinguishes that adjacent fragment and AOD-9604 from the exact 176–191 label.

No authenticated human exact-fragment product, concentration-time study or validated analytical identity was found; animal 177–191 and AOD-9604 results are not interchangeable.

Felt duration people report

The checked reports do not establish a fragment-specific felt-duration window because null reports are common and positive outcomes are diet- or polypharmacy-confounded.

One user described four-week blocks with diet/cardio, another reported zero weight loss across varied schedules, and an 18-month positive account disclosed multiple weight-loss and GH-axis agents.

Anonymous self-selection, unauthenticated products, body-composition outcomes rather than per-dose sensation, inconsistent schedules and major stack confounding prevent a duration range.

Other context in this card

What people say 5

  • Lipolysis lore: Community fat-loss talk; human evidence weaker than marketing. forum
  • Weight-loss reports conflict: One user said a fasted split schedule only appeared useful with diet/cardio, several users reported no weight loss, and a long positive report disclosed tirzepatide, retatrutide, GH secretagogues and many other peptides. forum
  • No established progression: HGH fragment 176–191 is not an incretin-class agent, and the checked community material contains inconsistent amounts without a controlled human dose-ranging study of the exact named fragment. forum
  • Muscle-loss worry: Rapid loss logs often add protein + lifting caveats. forum
  • Access reality: Compounding vs brand vs research-chem paths change purity and dose confidence. forum

Doses people talk about 6

  • Most common community band: ~200–500 mcg/day subcutaneous, often fasted (AM and/or pre-bed). forum
  • Split-dose culture: ~250 mcg twice daily (≈ 500 mcg/day total) is a very common “standard cut” template. forum
  • Higher talk: some logs push ~500–1000 mcg/day total; clinical oral AOD-class trials used different routes/amounts — do not equate blindly. forumtrial
  • Timing lore: empty-stomach morning and/or night pins dominate forum charts; peri-workout is secondary. forum
  • Block length: often ~4–12 weeks on fat-loss blogs, sometimes with washout weeks. forum
  • Framing: Community fat-loss peptide talk (often lumped with AOD-9604 culture). Not a GH replacement dose. forum

How it may feel 5

  • No common early feel: The checked reports emphasize disputed body-composition outcomes rather than a reproducible immediate sensation; several users reported no noticeable benefit, and positive reports were diet- or stack-confounded. forum
  • Weeks: Subtle bodycomp experiments. forum
  • Day 1: Most people notice logistics (route, sting, GI) more than a “miracle” effect from HGH Fragment 176-191. forum
  • Days 2–7: Side-effect window for many agents; benefits, if any, are easy to mis-attribute. forum
  • Weeks 1–2: First honest checkpoint in self-logs. forum

Around the dose 3

  • Clock: Morning fasted, sometimes with a second dose. Night food fights the “frag window.” forum
  • Training: Fasted walk/cardio after is the classic pairing. forum
  • After: Don’t immediately slam a huge carb meal if the chart you copied was a fasted one. forum

Cycles people discuss 4

  • Reported blocks conflict: One user described four weeks on, sometimes two weeks off, then another four weeks; another planned ten weeks in a stack; a heavily confounded positive account described 18 months without breaks. No standard cycle is established. forum
  • Common pattern: Many self-protocols use weeks-on / weeks-off rather than indefinite daily use — cost and caution drive this more than hard science. forum
  • No magic cycle: There is rarely one universal “correct” on/off calendar across forums. forum
  • Reassess: Stop and reassess if adverse effects appear; this is not medical care. forum

Timing 3

  • Human PK not established: The checked sources provide no numerical parent-compound half-life for exact HGH fragment 176–191. Multi-daily forum schedules are behavior, not pharmacokinetic measurement. forum
  • Timing practicalities: People time doses around side effects, training, and sleep more than perfect PK. forum
  • Wrong-class timing removed: Incretin, amylin and ghrelin schedules do not establish the kinetics of HGH fragment 176–191. Adjacent AOD-9604 or hGH 177–191 evidence also cannot supply an exact-fragment half-life. forumanimal

More on what it is 5

  • What it is: HGH fragment 176–191 is a gray-market name for the C-terminal region of human growth hormone. It is not identical to AOD-9604 (Tyr-hGH 177–191) or the hGH 177–191 fragment studied in rats, so evidence cannot be transferred without qualification. forumanimal
  • See also: Related to AOD-9604 / frag entries already in catalog. forum
  • Research posture: Educational summary of public discussion and literature themes only. forum
  • How people talk about it: Forum volume is a popularity signal for HGH Fragment 176-191, not proof it works for you. forum
  • Research only: Not approved advice for self-experimentation; legality and access vary by place. forum

Stacks 2

  • With cardio / deficit: community forum
  • Less is clearer: Solo runs make personal n=1 easier to interpret than five-compound blasts. forum

Storage notes 2

  • No mix instructions here: STUDresearch does not list reconstitution, diluent volumes, or syringe unit charts. People reconstitute many different ways and vial labels differ — that content creates more confusion than clarity. forum
  • Storage (general talk only): Unopened research products are usually kept cool, dry, and away from light per the seller label. Anything after first use is product-specific — follow the label, not a universal forum SOP. forum

Watch for 6

  • Injection site: community forum
  • Underwhelming results common: anecdote forum
  • Injection site (if injected): Redness, itch, lumps, bruise — technique and product quality matter. forum
  • Unknowns: Long-term safety for gray-market preparations is often poorly characterized. forum
  • Stack noise: Sides logged on multi-agent stacks cannot be blamed cleanly on one compound. forum
  • Seek care red flags: Severe allergic reaction, chest pain, neuro changes, or uncontrolled BP/glucose need real medical care — not forum advice. forum

Updated: 2026-08-21

Evidence mix Mostly community / anecdote tags Full: every bullet (trial + community). Use Scan for a faster bro-science read.

All STUDresearch topics →